The identity and function of every cell is defined by which ‘genetic programs’ are active at any particular time. Dr. Mark Kotter, CEO and Founder at bit.bio, explains the breakthrough technology which, put simply, enables consistent reprogramming of cells based on the reliable activation of specific genes and
these genetic programs.
Current Edition
Current Features
Subsection - Neurodegenerative Diseases
From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment
Continue reading
Transforming Drug Discovery and Medicine Research
IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.
Bio Pharmaceutical Media © 2026, All Rights Reserved – Powered by Teksyte